Roundtable

[RT2] Sharing Ideas on Pre-Approval Information Exchange Implementation

ACPE UAN: 0233-0000-19-045-L04-P | Contact Hours: 0.5 | Activity Type: Knowledge-based

Faculty(s)

• 

  Elisabeth Brisley, MPH

  Legislative Analyst
  Academy of Managed Care Pharmacy
  Alexandria, Virginia
• 

  Amy Duhig, PhD

  Vice President, Consulting Services
  Xcenda, LLC
  Palm Harbor, Florida
• 

  Sheila M. Thomas, PharmD

  Global Head, Patient Insights and Engagement Strategy
  Sanofi, Inc.
  Bridgewater, New Jersey

Please note, space is limited to approximately 30 participants on a first come, first served basis. This learning activity will be offered twice: 4:30 pm to 4:55 pm (round 1) and 5:05 pm to 5:30 pm (round 2).

This roundtable will feature three subject matter experts to help facilitate a discussion amongst attendees on implementing pre-approval information exchange between biopharmaceutical companies and formulary decision-makers. Attendees will share their experiences with each other to help inform this peer-to-peer information exchange.

How can you prepare for this roundtable?

• Attend the prerequisite session titled, [F4] The Road to Pre-Approval Information Exchange: Where Are We Today?
• Download and review all handout material prior to participating in this roundtable.

Recommended audience: Managed care professionals working in health plans and biopharmaceutical companies interested in discussing implementation of pre-approval information.

Learning Objectives:

At the completion of this activity, participants should be able to:

1. Summarize opportunities and challenges for implementing pre-approval information exchange among formulary decision-makers and biopharmaceutical companies.